0001209191-20-034226.txt : 20200603
0001209191-20-034226.hdr.sgml : 20200603
20200603185021
ACCESSION NUMBER: 0001209191-20-034226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200602
FILED AS OF DATE: 20200603
DATE AS OF CHANGE: 20200603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnston Walt
CENTRAL INDEX KEY: 0001813699
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20941418
MAIL ADDRESS:
STREET 1: UROVANT SCIENCES LTD.
STREET 2: 5281 CALIFORNIA AVE SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-02
0
0001740547
Urovant Sciences Ltd.
UROV
0001813699
Johnston Walt
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVE. SUITE 100
IRVINE
CA
92617
0
1
0
0
SVP, Commercial, USI
Common Shares
2020-06-02
4
A
0
108647
0.00
A
108647
D
Stock Option (Right to Buy)
10.64
2020-06-02
4
A
0
69197
0.00
A
2030-06-02
Common Shares
69197
69197
D
25% of the Restricted Stock Units shall vest on June 1, 2021; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
25% of the total shares underlying the option shall vest and become exercisable on June 1, 2021; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
/s/ Bryan Smith, Attorney-in-Fact
2020-06-03